Fig. 2.
Trend of inclusion of pre-menopausal breast cancer patients in phase III clinical trials over time. Year represents the year of clinical trial opening. Abbreviations: pre-menopausal breast cancer (PMBC), hormone-receptor-positive and HER2-negative breast cancer subtype (HR+/HER2-), endocrine therapy (ET).